Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COHERENT - Colchicine Hypertension Trial
2020-004492-40Phase 2Active
- Sponsor
- Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev and Gentofte Hospital
- Start
- Oct 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypertension (HTN) comparing Colchicine with Placebo (2 arms). Primary endpoint: Change in carotid-femoral pulse wave velocity. Started Oct 2020; status: active.
02
Drugs
colchicine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2020-004492-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004492-40.